Purchase Order 75N95023P00584
Award Date 9/20/23
Potential Completion Date 1/19/24
Potential Value $135K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Xenobiotic Laboratories Inc. Biotesting Division was awarded a $71,740 firm fixed price purchase order by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to assess the cytochrome P450 (CYP450) enzyme induction potential of two test articles. Performance will take place in Plainsboro Township, New Jersey from August 2023 through March 2024. The award is in response to a solicitation requesting evaluation of the test...
- Xenobiotic Laboratories Inc. was awarded a firm fixed price delivery order against the Analytical Services Center for Medications Development Program for analytical services. The delivery order, valued at $0.00 with a period of performance from September 25, 2019 through May 23, 2022, was issued by the National Institute on Drug Abuse, part of the Department of Health and Human Services National Institutes of Health. Under the delivery order, Xenobiotic Laboratories Inc.'s Biotesting Division...
- This is a $107,700.00 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health, to Curia Global Inc. (doing business as Amri) for cGMP mitragynine HCl supplemental stability and analytical activities. The work supports the preclinical development of mitragynine as part of NCATS' Helping to End Addiction Long-term (HEAL) initiative. Curia, a leading contract development and manufacturing organization,...
- Xenobiotic Laboratories Inc. was awarded a firm fixed price delivery order against the Analytical Services Center for Medications Development Program for analytical services. The one year, $0.00 potential value task order was awarded by the National Institute on Drug Abuse within the Department of Health and Human Services to support the Center's work developing medications. Performance will take place in Plainsboro Township, New Jersey by Xenobiotic's Biotesting Division. No set aside...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $45,717 firm fixed price purchase order to Xenotech LLC, doing business as Sekisui-Xenotech, for the provision of cryopreserved human, mouse, and rat hepatocytes. The solicitation sought these hepatocytes for use in drug metabolism experiments to support the National Institute on Drug Abuse's malaria research project and understand drug metabolism in...
- This is a purchase order awarded by the U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse (NIDA) to Xenotech LLC, a small disadvantaged business doing business as Sekisui-Xenotech. The $41,496 firm fixed price contract is for the delivery of 300 vials (1mL each) of "Mixed Gender Human Liver Microsomes" to support the National Center for Advancing Translational Sciences (NCATS) Tox21 program's research on drug metabolism and...
- The National Institute on Drug Abuse (NIDA), on behalf of the National Center for Advancing Translational Sciences (NCATS), awarded a $99,000 firm fixed-price purchase order to Life Technologies Corporation, doing business as Thermo Fisher Scientific, to independently provide services to obtain kinases' percent inhibition for 5,000 data points at one concentration and 400 IC50 curves of malaria compounds. This non-competitive acquisition leverages Life Technologies' specialized expertise in...
- This is a $80,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is part of the Department of Health and Human Services (HHS). The contract has a total small business set aside and was awarded to the prime contractor Human Metabolome Technologies America, Inc., a Japan-based biotechnology company specializing in metabolomics. The contract engages Human Metabolome Technologies America to provide a range of testing, laboratory, and analytical...
- The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $6,338 firm fixed price purchase order to Cyprotex US LLC for ADME-TOX screening services in support of preliminary safety assessment of a new lead candidate for the agency's HER3 receptor project. Work will be performed by Cyprotex US LLC Division in Watertown, Massachusetts over a one year period concluding on August 30, 2024. The award was made using...
- This is a $80,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), which is part of the U.S. Department of Health and Human Services. The contract was awarded to Human Metabolome Technologies America, Inc., a small disadvantaged business based in Allston, Massachusetts. The contract is for metabolomics analysis services, including metabolomic assays, lipidomic analyses, targeted metabolomics, data acquisition, and testing methodologies. The...